Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
159.8 USD | +2.11% | +8.36% | -10.75% |
04-23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
04-23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.75% | 16.36B | |
-1.58% | 104B | |
+3.22% | 97.47B | |
+5.41% | 22.25B | |
-13.96% | 21.68B | |
-9.40% | 18.2B | |
-39.98% | 17.02B | |
+7.05% | 14.39B | |
+39.45% | 12.37B | |
+297.98% | 8.43B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene : Ladenburg Thalmann Downgrades BeiGene to Neutral from Buy